/newsfirstprime/media/post_attachments/wp-content/uploads/2025/04/WhatsApp-Image-2025-04-16-at-11.50.38-AM-1.jpeg)
Speaking at the Lifesciences and Healthcare Innovation Forum (LHIF) 2025, Phanindra Mothay, Senior Director of Maternal Fetal Care at GE Healthcare, highlighted the transformative potential of AI in maternal and neonatal care.
Also Read: AI revolutionizing the pharmaceutical industry: Naveen Gullapalli at LHIF 2025
Introducing GE Healthcare as a $20 billion global healthcare equipment conglomerate operating across 180 countries, Mothay shared that their advanced design center in India is capable of creating medical products for the world. "The smallest premature baby we’ve saved with our equipment was just 20 weeks old," he noted. "Only a few doctors and hospitals can handle such cases, but this capability should be available everywhere to save lives."
He announced GE’s upcoming innovation, Fetal Heart Rate AI, a tool designed to monitor a baby’s condition in the womb using two key parameters which are fetal heart rate and uterine contractions. “This AI will allow doctors anywhere in the world to access insights and suggestions, bridging the gap between a top-tier U.S. doctor and a village doctor in Africa,” Mothay explained.
He stressed the power of AI to revolutionize maternal care, from simple verification tasks to life-saving interventions, potentially reducing global infant and maternal mortality rates.
Concluding, Mothay said GE Healthcare and NASSCOM are working together to take these innovations to grassroots levels. “Bengaluru is becoming the AI engine for the world,” he said, expressing hope for a future with fewer problems and more solutions through technology.